HUM vs. ICLR: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at HUM and ICLR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | HUM | ICLR |
|---|---|---|
| Company Name | Humana Inc. | ICON Public Limited Company |
| Country | United States | Ireland |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Providers & Services | Life Sciences Tools & Services |
| Market Capitalization | 35.75 billion USD | 13.53 billion USD |
| Exchange | NYSE | NasdaqGS |
| Listing Date | December 31, 1981 | May 15, 1998 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of HUM and ICLR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | HUM | ICLR |
|---|---|---|
| 5-Day Price Return | 0.95% | -0.97% |
| 13-Week Price Return | 31.18% | 32.44% |
| 26-Week Price Return | 16.16% | -13.60% |
| 52-Week Price Return | -15.79% | -46.13% |
| Month-to-Date Return | 18.97% | 2.84% |
| Year-to-Date Return | 17.17% | -17.03% |
| 10-Day Avg. Volume | 1.28M | 0.88M |
| 3-Month Avg. Volume | 1.75M | 1.50M |
| 3-Month Volatility | 37.03% | 57.69% |
| Beta | 0.47 | 1.25 |
Profitability
Return on Equity (TTM)
HUM
9.02%
Health Care Providers & Services Industry
- Max
- 26.03%
- Q3
- 13.74%
- Median
- 8.26%
- Q1
- 4.13%
- Min
- -3.62%
HUM’s Return on Equity of 9.02% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
ICLR
8.28%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.55%
- Median
- 6.22%
- Q1
- 3.86%
- Min
- -6.95%
ICLR’s Return on Equity of 8.28% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
HUM
1.28%
Health Care Providers & Services Industry
- Max
- 12.40%
- Q3
- 5.93%
- Median
- 1.96%
- Q1
- 0.93%
- Min
- -6.10%
HUM’s Net Profit Margin of 1.28% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
ICLR
9.82%
Life Sciences Tools & Services Industry
- Max
- 27.28%
- Q3
- 16.17%
- Median
- 7.24%
- Q1
- 3.00%
- Min
- -3.05%
ICLR’s Net Profit Margin of 9.82% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
HUM
2.68%
Health Care Providers & Services Industry
- Max
- 19.05%
- Q3
- 10.21%
- Median
- 4.22%
- Q1
- 1.98%
- Min
- -4.27%
HUM’s Operating Profit Margin of 2.68% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
ICLR
12.50%
Life Sciences Tools & Services Industry
- Max
- 33.15%
- Q3
- 19.34%
- Median
- 13.02%
- Q1
- 8.05%
- Min
- -4.38%
ICLR’s Operating Profit Margin of 12.50% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | HUM | ICLR |
|---|---|---|
| Return on Equity (TTM) | 9.02% | 8.28% |
| Return on Assets (TTM) | 3.19% | 4.71% |
| Net Profit Margin (TTM) | 1.28% | 9.82% |
| Operating Profit Margin (TTM) | 2.68% | 12.50% |
| Gross Profit Margin (TTM) | -- | 28.65% |
Financial Strength
Current Ratio (MRQ)
HUM
0.01
Health Care Providers & Services Industry
- Max
- 2.01
- Q3
- 1.49
- Median
- 1.30
- Q1
- 0.94
- Min
- 0.17
HUM’s Current Ratio of 0.01 is notably low, falling beneath the typical range for the Health Care Providers & Services industry. This suggests a heightened liquidity risk and could indicate potential challenges in meeting its short-term obligations.
ICLR
1.29
Life Sciences Tools & Services Industry
- Max
- 4.76
- Q3
- 2.77
- Median
- 1.85
- Q1
- 1.40
- Min
- 0.43
ICLR’s Current Ratio of 1.29 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
HUM
0.69
Health Care Providers & Services Industry
- Max
- 2.17
- Q3
- 1.18
- Median
- 0.74
- Q1
- 0.45
- Min
- 0.00
HUM’s Debt-to-Equity Ratio of 0.69 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
ICLR
0.36
Life Sciences Tools & Services Industry
- Max
- 1.75
- Q3
- 0.83
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
ICLR’s Debt-to-Equity Ratio of 0.36 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
HUM
3.61
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.15
- Median
- 5.45
- Q1
- 2.04
- Min
- -4.44
HUM’s Interest Coverage Ratio of 3.61 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.
ICLR
4.80
Life Sciences Tools & Services Industry
- Max
- 29.61
- Q3
- 23.24
- Median
- 6.07
- Q1
- 2.18
- Min
- -14.08
ICLR’s Interest Coverage Ratio of 4.80 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | HUM | ICLR |
|---|---|---|
| Current Ratio (MRQ) | 0.01 | 1.29 |
| Quick Ratio (MRQ) | 0.01 | 1.24 |
| Debt-to-Equity Ratio (MRQ) | 0.69 | 0.36 |
| Interest Coverage Ratio (TTM) | 3.61 | 4.80 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
HUM
1.25%
Health Care Providers & Services Industry
- Max
- 5.38%
- Q3
- 2.22%
- Median
- 0.55%
- Q1
- 0.00%
- Min
- 0.00%
HUM’s Dividend Yield of 1.25% is consistent with its peers in the Health Care Providers & Services industry, providing a dividend return that is standard for its sector.
ICLR
0.00%
Life Sciences Tools & Services Industry
- Max
- 1.80%
- Q3
- 0.78%
- Median
- 0.37%
- Q1
- 0.00%
- Min
- 0.00%
ICLR currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
HUM
14.15%
Health Care Providers & Services Industry
- Max
- 186.69%
- Q3
- 74.82%
- Median
- 26.76%
- Q1
- 0.00%
- Min
- 0.00%
HUM’s Dividend Payout Ratio of 14.15% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
ICLR
0.00%
Life Sciences Tools & Services Industry
- Max
- 156.00%
- Q3
- 65.73%
- Median
- 23.81%
- Q1
- 0.00%
- Min
- 0.00%
ICLR has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | HUM | ICLR |
|---|---|---|
| Dividend Yield (TTM) | 1.25% | 0.00% |
| Dividend Payout Ratio (TTM) | 14.15% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
HUM
21.85
Health Care Providers & Services Industry
- Max
- 55.89
- Q3
- 30.85
- Median
- 21.17
- Q1
- 12.63
- Min
- 0.00
HUM’s P/E Ratio of 21.85 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
ICLR
17.61
Life Sciences Tools & Services Industry
- Max
- 117.96
- Q3
- 65.59
- Median
- 37.26
- Q1
- 27.51
- Min
- 1.73
In the lower quartile for the Life Sciences Tools & Services industry, ICLR’s P/E Ratio of 17.61 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
Price-to-Sales Ratio (TTM)
HUM
0.28
Health Care Providers & Services Industry
- Max
- 3.10
- Q3
- 1.74
- Median
- 0.67
- Q1
- 0.24
- Min
- 0.00
HUM’s P/S Ratio of 0.28 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
ICLR
1.73
Life Sciences Tools & Services Industry
- Max
- 12.46
- Q3
- 6.70
- Median
- 4.24
- Q1
- 2.68
- Min
- 0.73
In the lower quartile for the Life Sciences Tools & Services industry, ICLR’s P/S Ratio of 1.73 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
Price-to-Book Ratio (MRQ)
HUM
1.62
Health Care Providers & Services Industry
- Max
- 7.61
- Q3
- 4.32
- Median
- 2.53
- Q1
- 1.14
- Min
- 0.77
HUM’s P/B Ratio of 1.62 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
ICLR
1.21
Life Sciences Tools & Services Industry
- Max
- 7.99
- Q3
- 4.69
- Median
- 3.30
- Q1
- 1.88
- Min
- 1.02
ICLR’s P/B Ratio of 1.21 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
Valuation at a Glance
| Symbol | HUM | ICLR |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 21.85 | 17.61 |
| Price-to-Sales Ratio (TTM) | 0.28 | 1.73 |
| Price-to-Book Ratio (MRQ) | 1.62 | 1.21 |
| Price-to-Free Cash Flow Ratio (TTM) | 11.03 | 14.14 |